New Drug Approvals for Prostate Cancer

被引:0
|
作者
Tannock, Ian F. [1 ]
机构
[1] Univ Toronto, Princess Margaret Canc Ctr, Med & Med Biophys, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:245 / 246
页数:2
相关论文
共 50 条
  • [11] New drug approvals in oncology
    Kurzrock, Razelle
    Kantarjian, Hagop M.
    Kesselheim, Aaron S.
    Sigal, Ellen V.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2020, 17 (03) : 140 - 146
  • [12] PMA ON NEW DRUG APPROVALS
    STETLER, CJ
    [J]. AMERICAN PHARMACY, 1978, 18 (03): : 5 - 5
  • [13] Approvals in 2021: dangling Accelerated Approvals, drug dosing, new approvals and beyond
    Lemery, Steven
    Pazdur, Richard
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (04) : 217 - 218
  • [14] Approvals in 2021: dangling Accelerated Approvals, drug dosing, new approvals and beyond
    Steven Lemery
    Richard Pazdur
    [J]. Nature Reviews Clinical Oncology, 2022, 19 : 217 - 218
  • [15] New drug for prostate cancer
    不详
    [J]. EUROPEAN JOURNAL OF CANCER CARE, 2001, 10 (02) : 79 - 80
  • [16] NEW DRUG FOR PROSTATE CANCER
    Aschenbrenner, Diane S.
    [J]. AMERICAN JOURNAL OF NURSING, 2019, 119 (11) : 21 - 21
  • [17] Endpoints used by the FDA for new drug approvals for treatment (TT) of advanced (ADV) cancer: Example of hormone refractory prostate cancer (HRPC).
    Mann, BS
    Dagher, R
    Williams, G
    Johnson, J
    Pazdur, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 545S - 545S
  • [18] Metastasis-Free Survival in Prostate Cancer: Faster Drug Approvals, Better Drugs?
    Parikh, Ravi B.
    Prasad, Vinay
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04) : 266 - +
  • [19] New drug for pancreatic cancer highlights the dual effect of regulatory approvals
    Susan E. Bates
    Tito Fojo
    [J]. Nature Reviews Clinical Oncology, 2016, 13 : 205 - 206
  • [20] Cancer Drug Approvals Rise in 2012
    不详
    [J]. CANCER DISCOVERY, 2013, 3 (03) : 243 - 244